Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanaz Gabery

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Huntington'S Disease|July 27, 2014
Hypothalamic and Limbic System Changes in Huntington's DiseaseAsa Petersén, Sanaz Gabery
Journal of Huntington'S Disease|October 10, 2019
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's DiseaseRachel Y Cheong, Sanaz Gabery, Åsa Petersén
Frontiers in Molecular Neuroscience|October 3, 2022
Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementiaSofia Bergh, Rachel Y Cheong, Åsa Petersén, et al.
The European Journal of Neuroscience|June 27, 2012
Characterization of a rat model of Huntington's disease based on targeted expression of mutant huntingtin in the forebrain using adeno-associated viral vectorsSanaz Gabery, Muhammad U Sajjad, Sofia Hult, et al.
Neuropathology and Applied Neurobiology|February 13, 2023
Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington's diseaseSofia Bergh, Sanaz Gabery, Simone Tonetto, et al.
Neuropathology and Applied Neurobiology|March 23, 2021
Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosisSanaz Gabery, Rebekah M Ahmed, Jashelle Caga, et al.
Life Sciences|July 8, 2025
Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintideSanaz Gabery, Tine Glendorf, Borja Ballarin-Gonzalez, et al.
Acta Neuropathologica|September 8, 2010
Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analysesSanaz Gabery, Karen Murphy, Kristofer Schultz, et al.
Clinical Endocrinology|August 8, 2020
Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood-onset craniopharyngiomaSigridur Fjalldal, Lars Rylander, Danielle van Westen, et al.
Annals of Neurology|March 10, 2011
Eating and hypothalamus changes in behavioral-variant frontotemporal dementiaOlivier Piguet, Asa Petersén, Bonnie Yin Ka Lam, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Huntington'S Disease|July 27, 2014
Hypothalamic and Limbic System Changes in Huntington's DiseaseAsa Petersén, Sanaz Gabery
Journal of Huntington'S Disease|October 10, 2019
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's DiseaseRachel Y Cheong, Sanaz Gabery, Åsa Petersén
Frontiers in Molecular Neuroscience|October 3, 2022
Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementiaSofia Bergh, Rachel Y Cheong, Åsa Petersén, et al.
The European Journal of Neuroscience|June 27, 2012
Characterization of a rat model of Huntington's disease based on targeted expression of mutant huntingtin in the forebrain using adeno-associated viral vectorsSanaz Gabery, Muhammad U Sajjad, Sofia Hult, et al.
Neuropathology and Applied Neurobiology|February 13, 2023
Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington's diseaseSofia Bergh, Sanaz Gabery, Simone Tonetto, et al.
Neuropathology and Applied Neurobiology|March 23, 2021
Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosisSanaz Gabery, Rebekah M Ahmed, Jashelle Caga, et al.
Life Sciences|July 8, 2025
Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintideSanaz Gabery, Tine Glendorf, Borja Ballarin-Gonzalez, et al.
Acta Neuropathologica|September 8, 2010
Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analysesSanaz Gabery, Karen Murphy, Kristofer Schultz, et al.
Clinical Endocrinology|August 8, 2020
Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood-onset craniopharyngiomaSigridur Fjalldal, Lars Rylander, Danielle van Westen, et al.
Annals of Neurology|March 10, 2011
Eating and hypothalamus changes in behavioral-variant frontotemporal dementiaOlivier Piguet, Asa Petersén, Bonnie Yin Ka Lam, et al.
Pageof 3